Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
about
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapyOrganization of the human tarbp2 gene reveals two promoters that are repressed in an astrocytic cell lineRecruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencingThe SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repairRegulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoterOn the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosisCharacterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.Human immunodeficiency virus (HIV)-1 integration sites in viral latencyCD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cellsPredictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approachStructural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibodyDepletion of latent HIV-1 infection in vivo: a proof-of-concept studyInhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitorsCellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in EuropeEpigenetic regulation of HIV-1 latency by cytosine methylationHIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirsA stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patientsAn "escape clock" for estimating the turnover of SIV DNA in resting CD4⁺ T cellsResidual Viremia in Treated HIV+ IndividualsGrifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, GriffithsinAntiretroviral therapy: Shifting sandsThe HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind's future?Correlation of acute humoral response with brain virus burden and survival time in pig-tailed macaques infected with the neurovirulent simian immunodeficiency virus SIVsmmFGbBasal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1.Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors.Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapySelf-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state.Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activationModeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cellsAntiviral, immunomodulatory, and free radical scavenging activities of a protein-enriched fraction from the larvae of the housefly, Musca domesticaThe detection and management of early HIV infection: a clinical and public health emergency.Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccinationMacrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.
P2860
Q22251085-B28BC50C-B0A3-4598-822F-D4A40AF18858Q24291820-5904C678-D0A7-491B-9113-792FBD83110FQ24294385-F1A8C423-9BA8-4687-BD4F-7290889C607CQ24298284-B9E55E8B-073E-4892-9140-D1E8708D687FQ24634457-F9BFA2A4-D9F8-4FED-BFA8-6B25EEC7D472Q24645207-9FD556AF-0521-4FC3-B254-36DAA0397268Q24815984-471BC02B-364D-433B-8B68-808FBB31F388Q27026246-0AECD5DA-AD28-48C2-8992-B5F52381F14DQ27322949-BCCC331F-FCFC-47C2-B443-7057A04FC3EBQ27324340-B9EC2563-D507-4DA7-907C-2DAD38588CFCQ27677011-743C398B-4579-4A1B-A85C-F9E5BAFDDC6CQ28111910-C1AC5FDA-5571-41BE-833B-9222826E48D6Q28344365-F2DD608E-107B-4ADE-AC9C-D059B92FBDEAQ28474278-D1B7A814-F927-47BA-A588-2EAEC7AD2822Q28475636-9A13E034-79CF-410B-91F0-2F6DD5EE0EBBQ28477500-637F5495-34A4-4392-AE20-12E49A6EB0A1Q28477926-FD3DD638-4A6B-4F3D-9FB1-4D8B6CF16BE9Q28482134-74F6424C-2FB2-4C9F-B89A-241FB539F0A6Q28552126-D0B53933-DCC9-4562-A547-E923A724FA4CQ28744163-9F8B4503-4487-4310-821A-8A993A8BE2A8Q30384683-AD3CB998-D7AE-41B5-A912-6B3DE337C6A3Q30431054-EA245C98-E740-445F-B11B-ED8DADFFCF92Q30478136-F7C59221-318C-4CAF-A0FF-4639583EDB90Q30480091-9E2E8AA5-BCF0-4DF1-A611-B4116D1197B4Q30845033-9EA27B38-9CB5-445F-BC22-DA0B21721BFCQ33313038-22DDF95E-BCDA-4FBE-BA1C-B46B8FED84C0Q33326800-48E566B5-7F24-4FEE-A665-384FA594072BQ33367106-9C0810C1-E5D3-4A64-B260-190F62345693Q33373073-C30C435D-D899-4C7B-A148-CC4DEF4DDFA1Q33378492-41596B6F-AA89-4DFE-B6DB-461204669364Q33404066-97C2E94F-B1DA-4DD8-863D-CA9F964035E9Q33508788-EA0A0CD8-7737-4B01-A081-080C6C3BAE8CQ33510903-B595F761-B158-42EE-A8AD-787C3ED96AF0Q33549606-F8416E2F-D35F-4FF3-94B6-CFB32A95E35CQ33571471-8E593148-4F02-44B3-BE63-871B91DBEAB1Q33586581-05B091CE-6B31-42BC-B49D-C5EB5224248EQ33686847-E2A2D8C2-6C0D-4BC6-9053-FFA0D7D23A92Q33716348-596B9E93-80FD-4D73-8DBA-C0C2EF7015B1Q33826974-9070AA9C-4918-401C-8DE1-1E19815C1D54Q33847458-216E07E1-A342-4DC2-8EF9-90093C93EBF4
P2860
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Reservoirs for HIV-1: mechanis ...... es and antiretroviral therapy.
@ast
Reservoirs for HIV-1: mechanis ...... es and antiretroviral therapy.
@en
type
label
Reservoirs for HIV-1: mechanis ...... es and antiretroviral therapy.
@ast
Reservoirs for HIV-1: mechanis ...... es and antiretroviral therapy.
@en
prefLabel
Reservoirs for HIV-1: mechanis ...... es and antiretroviral therapy.
@ast
Reservoirs for HIV-1: mechanis ...... es and antiretroviral therapy.
@en
P2093
P1476
Reservoirs for HIV-1: mechanis ...... es and antiretroviral therapy.
@en
P2093
McArthur J
Siliciano RF
P304
P356
10.1146/ANNUREV.IMMUNOL.18.1.665
P577
2000-01-01T00:00:00Z